Skip to main content
Equibles

HARBOR CAPITAL ADVISORS, INC.

Position in VCEL — Vericel Corp

CIK 1039128 CHICAGO, IL
Back to VCEL Full portfolio

Position in VCEL

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$3,241,185
+$1,191,377 QoQ
Shares Held
72,852
+14.3% QoQ
Ownership
0.142%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VCEL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

HARBOR CAPITAL ADVISORS, INC. holds $33,616,297 across 29 Biotechnology names. VCEL ranks #3 (9.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TWST
Twist Bioscience Corp
 53,282 $5,481,652
2 KYMR
Kymera Therapeutics, Inc.
 36,368 $4,170,318
3 VCEL
Vericel Corp
This page 		72,852 $3,241,185
4 HALO
Halozyme Therapeutics, Inc.
 36,977 $2,894,189
5 RARE
Ultragenyx Pharmaceutical Inc.
 72,316 $2,414,631
6 CELC
Celcuity Inc.
 19,933 $2,085,390
7 TARS
Tarsus Pharmaceuticals, Inc.
 29,612 $1,863,779
8 AGIO
Agios Pharmaceuticals, Inc.
 46,550 $1,727,470

All Filings in VCEL

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,241,185 72,852
2026-03-31 $2,049,808 63,718